Avantax Planning Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-959
Closed -$203K 310
2019
Q3
$203K Buy
+959
New +$200K 0.01% 294
2018
Q4
Sell
-774
Closed -$132K 445
2018
Q3
$132K Buy
+774
New +$130K 0.01% 290
2018
Q2
Sell
-1,013
Closed -$164K 461
2018
Q1
$164K Buy
+1,013
New +$161K 0.01% 326
2017
Q4
Sell
-2,939
Closed -$399K 322
2017
Q3
$399K Buy
2,939
+2
+0.1% +$253 0.03% 238
2017
Q2
$368K Buy
2,937
+13
+0.4% +$1.55K 0.03% 226
2017
Q1
$347K Sell
2,924
-1,401
-32% -$168K 0.03% 226
2016
Q4
$499K Buy
+4,325
New +$481K 0.05% 162

Other funds holding CME

Avantax Planning Partners's CME Position: Q4 2019 in Review

Avantax Planning Partners sold out of CME Group (CME) in Q4 2019, closing a stake of 959 shares — an estimated $203K sold.

Avantax Planning Partners first reported a position in CME in Q4 2016 and held it in 7 quarters. The position peaked at $499K in Q4 2016. 1,060 funds tracked by Wall St. Rank hold CME as of Q4 2019.

  • Avantax Planning Partners reported no remaining CME Group position as of Q4 2019 after selling out during the quarter.
  • Avantax Planning Partners sold 959 CME Group shares in Q4 2019, an estimated $203K.
  • Avantax Planning Partners first reported a position in CME Group in Q4 2016 and held it in 7 quarters.
  • Avantax Planning Partners's CME Group position peaked at $499K in Q4 2016.
  • 1,060 funds tracked by Wall St. Rank held CME Group as of Q4 2019.

Based on Avantax Planning Partners's 13F filing for Q4 2019, filed 15 Jan 2020.